Literature DB >> 22015845

Applying label-free dynamic mass redistribution technology to frame signaling of G protein-coupled receptors noninvasively in living cells.

Ralf Schröder1, Johannes Schmidt, Stefanie Blättermann, Lucas Peters, Nicole Janssen, Manuel Grundmann, Wiebke Seemann, Dorina Kaufel, Nicole Merten, Christel Drewke, Jesus Gomeza, Graeme Milligan, Klaus Mohr, Evi Kostenis.   

Abstract

Label-free dynamic mass redistribution (DMR) is a cutting-edge assay technology that enables real-time detection of integrated cellular responses in living cells. It relies on detection of refractive index alterations on biosensor-coated microplates that originate from stimulus-induced changes in the total biomass proximal to the sensor surface. Here we describe a detailed protocol to apply DMR technology to frame functional behavior of G protein-coupled receptors that are traditionally examined with end point assays on the basis of detection of individual second messengers, such as cAMP, Ca(2+) or inositol phosphates. The method can be readily adapted across diverse cellular backgrounds (adherent or suspension), including primary human cells. Real-time recordings can be performed in 384-well microtiter plates and be completed in 2 h, or they can be extended to several hours depending on the biological question to be addressed. The entire procedure, including cell harvesting and DMR detection, takes 1-2 d.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22015845     DOI: 10.1038/nprot.2011.386

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  32 in total

1.  A holistic view of GPCR signaling.

Authors:  Terry Kenakin
Journal:  Nat Biotechnol       Date:  2010-09       Impact factor: 54.908

Review 2.  How many drug targets are there?

Authors:  John P Overington; Bissan Al-Lazikani; Andrew L Hopkins
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

Review 3.  Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors.

Authors:  Terry Kenakin
Journal:  Trends Pharmacol Sci       Date:  2007-07-13       Impact factor: 14.819

Review 4.  The evasive nature of drug efficacy: implications for drug discovery.

Authors:  Ségolène Galandrin; Geneviève Oligny-Longpré; Michel Bouvier
Journal:  Trends Pharmacol Sci       Date:  2007-07-19       Impact factor: 14.819

5.  On the mechanism of interaction of potent surmountable and insurmountable antagonists with the prostaglandin D2 receptor CRTH2.

Authors:  Jesper Mosolff Mathiesen; Arthur Christopoulos; Trond Ulven; Julia F Royer; Mercedes Campillo; Akos Heinemann; Leonardo Pardo; Evi Kostenis
Journal:  Mol Pharmacol       Date:  2006-01-17       Impact factor: 4.436

6.  Comparing label-free biosensors for pharmacological screening with cell-based functional assays.

Authors:  Matthew F Peters; François Vaillancourt; Madeleine Heroux; Manon Valiquette; Clay W Scott
Journal:  Assay Drug Dev Technol       Date:  2010-04       Impact factor: 1.738

Review 7.  7TM pharmacology measured by label-free: a holistic approach to cell signalling.

Authors:  Magalie Rocheville; Jeff C Jerman
Journal:  Curr Opin Pharmacol       Date:  2009-08-09       Impact factor: 5.547

8.  Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors.

Authors:  Mounia Azzi; Pascale G Charest; Stéphane Angers; Guy Rousseau; Trudy Kohout; Michel Bouvier; Graciela Piñeyro
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-17       Impact factor: 11.205

9.  Discovery of potent and selective agonists for the free fatty acid receptor 1 (FFA(1)/GPR40), a potential target for the treatment of type II diabetes.

Authors:  Elisabeth Christiansen; Christian Urban; Nicole Merten; Kathrin Liebscher; Kasper K Karlsen; Alexandra Hamacher; Andreas Spinrath; Andrew D Bond; Christel Drewke; Susanne Ullrich; Matthias U Kassack; Evi Kostenis; Trond Ulven
Journal:  J Med Chem       Date:  2008-11-27       Impact factor: 7.446

10.  Neutrophil apoptosis mediated by nicotinic acid receptors (GPR109A).

Authors:  G Kostylina; D Simon; M F Fey; S Yousefi; H U Simon
Journal:  Cell Death Differ       Date:  2007-10-12       Impact factor: 15.828

View more
  61 in total

1.  Planar Photonic Crystal Biosensor for Quantitative Label-Free Cell Attachment Microscopy.

Authors:  Weili Chen; Kenneth D Long; Jonas Kurniawan; Margaret Hung; Hojeong Yu; Brendan A Harley; Brian T Cunningham
Journal:  Adv Opt Mater       Date:  2015-08-22       Impact factor: 9.926

2.  Dynamic ligand binding dictates partial agonism at a G protein-coupled receptor.

Authors:  Andreas Bock; Brian Chirinda; Fabian Krebs; Regina Messerer; Julia Bätz; Mathias Muth; Clelia Dallanoce; Dominika Klingenthal; Christian Tränkle; Carsten Hoffmann; Marco De Amici; Ulrike Holzgrabe; Evi Kostenis; Klaus Mohr
Journal:  Nat Chem Biol       Date:  2013-11-10       Impact factor: 15.040

3.  Bias analyses of preclinical and clinical D2 dopamine ligands: studies with immediate and complex signaling pathways.

Authors:  Tarsis F Brust; Michael P Hayes; David L Roman; Kevin D Burris; Val J Watts
Journal:  J Pharmacol Exp Ther       Date:  2014-12-24       Impact factor: 4.030

4.  Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids.

Authors:  Ning-Sheng Cai; César Quiroz; Jordi Bonaventura; Alessandro Bonifazi; Thomas O Cole; Julia Purks; Amy S Billing; Ebonie Massey; Michael Wagner; Eric D Wish; Xavier Guitart; William Rea; Sherry Lam; Estefanía Moreno; Verònica Casadó-Anguera; Aaron D Greenblatt; Arthur E Jacobson; Kenner C Rice; Vicent Casadó; Amy H Newman; John W Winkelman; Michael Michaelides; Eric Weintraub; Nora D Volkow; Annabelle M Belcher; Sergi Ferré
Journal:  J Clin Invest       Date:  2019-03-26       Impact factor: 14.808

Review 5.  Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4.

Authors:  G Milligan; E Alvarez-Curto; K R Watterson; T Ulven; B D Hudson
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

6.  α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands.

Authors:  Marta Sánchez-Soto; Verònica Casadó-Anguera; Hideaki Yano; Brian Joseph Bender; Ning-Sheng Cai; Estefanía Moreno; Enric I Canela; Antoni Cortés; Jens Meiler; Vicent Casadó; Sergi Ferré
Journal:  Mol Neurobiol       Date:  2018-03-18       Impact factor: 5.590

Review 7.  A Review of Single-Cell Adhesion Force Kinetics and Applications.

Authors:  Ashwini Shinde; Kavitha Illath; Pallavi Gupta; Pallavi Shinde; Ki-Taek Lim; Moeto Nagai; Tuhin Subhra Santra
Journal:  Cells       Date:  2021-03-05       Impact factor: 6.600

8.  Detection of free fatty acid receptor 1 expression: the critical role of negative and positive controls.

Authors:  Charlott-Amelie Teutsch; Madhura Panse; Manuel Grundmann; Gabriele Kaiser; Evi Kostenis; Hans-Ulrich Häring; Susanne Ullrich
Journal:  Diabetologia       Date:  2014-01-26       Impact factor: 10.122

9.  Agonists with supraphysiological efficacy at the muscarinic M2 ACh receptor.

Authors:  R Schrage; W K Seemann; J Klöckner; C Dallanoce; K Racké; E Kostenis; M De Amici; U Holzgrabe; K Mohr
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

10.  WNT Stimulation Dissociates a Frizzled 4 Inactive-State Complex with Gα12/13.

Authors:  Elisa Arthofer; Belma Hot; Julian Petersen; Katerina Strakova; Stefan Jäger; Manuel Grundmann; Evi Kostenis; J Silvio Gutkind; Gunnar Schulte
Journal:  Mol Pharmacol       Date:  2016-07-25       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.